ALMS Insider purchasing before upcoming catalyst

u/Emre_G010 · Reddit — r/biotech_stocks · January 05, 2026 at 10:00 · ⬆ 6 pts · 💬 15 comments  | View on Reddit ↗
AI Summary

Original Reddit post

Author sees ALMS insider buying and upcoming Phase 3 top-line results as a catalyst, viewing the Climb Bio milestone dispute as a buying opportunity.

ALMS — LONG The author is entering ALMS because insiders purchased $20 million of shares in November and December ahead of Phase 3 top-line results expected early Q1 2026. The dispute with Climb Bio over a $3 million milestone sent the share price down, which the author sees as a higher return entry. The primary catalyst is the upcoming Phase 3 data announcement.

Personally entering a position today and expecting the announcement sometime in January so best to enter asap.

Score 6
Comments 15
▶ Full Post Text
Ideas
u/Emre_G010 Reddit r/biotech_stocks
Long ALMS on insider buying and Phase 3 catalyst.
The author is entering ALMS because insiders purchased $20 million of shares in November and December ahead of Phase 3 top-line results expected early Q1 2026. The dispute with Climb Bio over a $3 million milestone sent the share price down, which the author sees as a higher return entry. The primary catalyst is the upcoming Phase 3 data announcement.
ALMS HIGH
More from Reddit — r/biotech_stocks
Help figuring out which stock this is.
Jan 04, 20:26
Before I step away from trading, I’ll share the strategy that carried me all these years
Jan 04, 15:08
Before I step away from trading, I’ll share the strategy that carried me all these years
Jan 04, 15:04
Biotech is hard — having the right framework makes it manageable
Jan 02, 20:20
Novo Nordisk - undervalued
Jan 02, 18:22

This Reddit post, published January 05, 2026, features u/Emre_G010 discussing ALMS. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/Emre_G010  · Tickers: ALMS